INNOVATIVE EYEWEAR, INC. Cost of Revenue
INNOVATIVE EYEWEAR, INC. (LUCY) reported Cost of Revenue of $768.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. cost of revenue for the quarter ending 2026-06-30 was $768.00K, a 29.75% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. cost of revenue for the quarter ending 2026-03-31 was $598.12K, a 155.64% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. cost of revenue for the quarter ending 2025-12-31 was $845.06K, a 41.56% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. cost of revenue for the quarter ending 2025-09-30 was $423.29K, a 117.90% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. cost of revenue for fiscal 2025 was $2.09M, a 47.35% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. cost of revenue for fiscal 2024 was $1.42M, a 11.75% increase from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. cost of revenue for fiscal 2023 was $1.27M, a 77.61% increase from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. cost of revenue for fiscal 2022 was $716.08K, a 32.02% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $768.00K 10-Q · filed 2026-08-14 | $1.37M 10-Q · filed 2026-08-14 | $2.21M derived: sum of 3 quarters · filed 2026-08-14 | $2.63M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $598.12K 10-Q · filed 2026-05-14 | $1.44M derived: sum of 2 quarters · filed 2026-05-14 | $1.87M derived: sum of 3 quarters · filed 2026-05-14 | $2.46M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $845.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.27M derived: sum of 2 quarters · filed 2026-03-25 | $1.86M derived: sum of 3 quarters · filed 2026-08-14 | $2.09M 10-K · filed 2026-03-25 |
| 2025-09-30 | $423.29K 10-Q · filed 2025-11-13 | $1.02M derived: sum of 2 quarters · filed 2026-08-14 | $1.25M 10-Q · filed 2025-11-13 | $1.85M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $591.89K 10-Q · filed 2026-08-14 | $825.86K 10-Q · filed 2026-08-14 | $1.42M derived: sum of 3 quarters · filed 2026-08-14 | $1.62M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $233.97K 10-Q · filed 2026-05-14 | $830.94K derived: sum of 2 quarters · filed 2026-05-14 | $1.03M derived: sum of 3 quarters · filed 2026-05-14 | $1.28M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $596.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $791.22K derived: sum of 2 quarters · filed 2026-03-25 | $1.04M derived: sum of 3 quarters · filed 2026-03-25 | $1.42M 10-K · filed 2026-03-25 |
| 2024-09-30 | $194.25K 10-Q · filed 2025-11-13 | $447.76K derived: sum of 2 quarters · filed 2025-11-13 | $824.28K 10-Q · filed 2025-11-13 | $1.62M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $253.51K 10-Q · filed 2025-08-14 | $630.03K 10-Q · filed 2025-08-14 | $1.43M derived: sum of 3 quarters · filed 2025-08-14 | $1.57M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $376.52K 10-Q · filed 2025-05-13 | $1.17M derived: sum of 2 quarters · filed 2025-05-13 | $1.31M derived: sum of 3 quarters · filed 2025-05-13 | $1.51M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $795.90K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $937.43K derived: sum of 2 quarters · filed 2025-03-24 | $1.14M derived: sum of 3 quarters · filed 2025-03-24 | $1.27M 10-K · filed 2025-03-24 |
| 2023-09-30 | $141.53K 10-Q · filed 2024-11-12 | $341.28K derived: sum of 2 quarters · filed 2024-11-12 | $475.91K 10-Q · filed 2024-11-12 | $739.76K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $199.75K 10-Q · filed 2024-08-12 | $334.38K 10-Q · filed 2024-08-12 | $598.23K derived: sum of 3 quarters · filed 2024-08-12 | $727.33K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $134.63K 10-Q · filed 2024-05-14 | $398.49K derived: sum of 2 quarters · filed 2024-05-14 | $527.58K derived: sum of 3 quarters · filed 2024-05-14 | $689.08K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $263.86K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $392.95K derived: sum of 2 quarters · filed 2024-03-25 | $554.45K derived: sum of 3 quarters · filed 2024-03-25 | $716.08K 10-K · filed 2024-03-25 |
| 2022-09-30 | $129.09K 10-Q · filed 2023-11-14 | $290.59K derived: sum of 2 quarters · filed 2023-11-14 | $452.22K 10-Q · filed 2023-11-14 | $662.26K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $161.49K 10-Q · filed 2023-08-11 | $323.13K 10-Q · filed 2023-08-11 | $533.16K derived: sum of 3 quarters · filed 2023-08-11 | $663.39K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $161.63K 10-Q · filed 2023-05-12 | $371.67K derived: sum of 2 quarters · filed 2023-05-12 | $501.89K derived: sum of 3 quarters · filed 2023-05-12 | $596.26K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $210.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $340.26K derived: sum of 2 quarters · filed 2023-03-24 | $434.63K derived: sum of 3 quarters · filed 2023-03-24 | $542.42K 10-K · filed 2023-03-24 |
| 2021-09-30 | $130.22K 10-Q · filed 2022-11-10 | $224.59K derived: sum of 2 quarters · filed 2022-11-10 | $332.38K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $94.37K 10-Q · filed 2022-09-26 | $202.16K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |